Local Institution

Sacramento, California 95817

0 studies enrolling now · 14 studies all time

What they study most

Bipolar Disorder, Chronic Genotype 1 Hepatitis C Virus Infection, Diabetes Mellitus II, Diabetes Mellitus, Type 2, Dyslipidemia, HIV Infections, Hypertension, Non-small Cell Lung Cancer, Pulmonary Embolism, Schizophrenia, Venous Thrombosis

Studies at this site

• Study Assessing Saxagliptin Treatment In Type 2 Diabetic Subjects Who Are Not Controlled With Metformin Alone — Completed
• Saxagliptin Treatment in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise — Completed
• Aripiprazole Open-Label, Safety and Tolerability Study — Completed
• Aripiprazole in Adolescents With Schizophrenia — Completed
• Aripiprazole in Children and Adolescents With Bipolar I Disorder — Completed
• Efficacy and Safety of BMS-298585 Alone or in Combination With Pravastatin in Subjects With Mixed Dyslipidemia — Completed
• A Phase 1b Study of PPI-461 in Patients With HCV Genotype 1 — Completed
• Switching HIV-1 Infected Subjects From a Highly Active Anti-Retroviral Treatment (HAART) Regimen Dosed Twice Daily or More Frequently to a Once-Daily Regimen — Completed
• Irbesartan/Hydrochlorothiazide (HCTZ) Combination Therapy for Patients With Moderate Hypertension — Completed
• Irbesartan/Hydrochlorothiazide (HCTZ) Combination Therapy as First Line Treatment for Severe Hypertension — Completed
• Atazanavir for HIV Infected Individuals: An Early Access Program — NO_LONGER_AVAILABLE
• Dose Ranging Study With LT, Monotherapy, PPAR — Completed
• BMS-562247 in Subjects Undergoing Elective Total Knee Replacement Surgery — Completed
• Study of BMS-275183 in Patients With Pre-treated Non-small Cell Lung Cancer — Stopped early